Timing of the vascular actions of estrogens in experimental and human studies: Why protective early, and not when delayed?

Maturitas

Volumn 68, Issue 2, 2011, Pages 165-173

  Lenfant, Franoise ^a   Trémollires, Florence ^a   Gourdy, Pierre ^a   Arnal, Jean Franois ^a  

^a University Hospital of Toulouse   (France)

Author keywords

Artery; Atheroma; Estradiol; Immune system; Ischemia; Menopause; Reendothelialization

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA;

ANGIOGENESIS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; ENDOTHELIUM; EXPERIMENTAL STUDY; HEART PROTECTION; HORMONAL THERAPY; HUMAN; INFLAMMATION; ISCHEMIA; ISCHEMIC HEART DISEASE; MENOPAUSE; NEOINTIMA; NONHUMAN; SEXUAL DEVELOPMENT; THROMBOSIS;

ANIMALIA;

EID: 78651387575     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.11.016     Document Type: Review

References (107)

1. M.F. Kalin, and B. Zumoff Sex hormones and coronary disease: a review of the clinical studies Steroids 55 1990 330 352
2. R.K. Dubey, B. Imthurn, M. Barton, and E.K. Jackson Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen Cardiovasc Res 66 2005 295 306
3. F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, and B. Rosner Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
4. T.B. Clarkson, and S.E. Appt Controversies about HRT - lessons from monkey models Maturitas 51 2005 64 74
5. P. Holm, H.L. Andersen, M.R. Andersen, E. Erhardtsen, and S. Stender The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits Circulation 100 1999 1727 1733
6. J.F. Arnal, P.Y. Scarabin, F. Tremollieres, H. Laurell, and P. Gourdy Estrogens in vascular biology and disease: where do we stand today? Curr Opin Lipidol 18 2007 554 560
7. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, and B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
8. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
9. M.R. Adams, T.C. Register, D.L. Golden, J.D. Wagner, and J.K. Williams Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis Arterioscler Thromb Vasc Biol 17 1997 217 221
10. J.E. Rossouw, R.L. Prentice, J.E. Manson, L. Wu, D. Barad, and V.M. Barnabei Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
11. J.C. Stevenson, H.N. Hodis, J.H. Pickar, and R.A. Lobo Coronary heart disease and menopause management: the swinging pendulum of HRT Atherosclerosis 207 2009 336 340
12. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, and H. Black Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
13. P. Ascenzi, A. Bocedi, and M. Marino Structure-function relationship of estrogen receptor alpha and beta: impact on human health Mol Aspects Med 27 2006 299 402
14. J.F. Arnal, C. Fontaine, A. Billon-Gales, J. Favre, H. Laurell, and F. Lenfant Estrogen receptors and endothelium Arterioscler Thromb Vasc Biol 30 2010 1506 1512
15. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res 53 2002 605 619
16. A.M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, and V. Bittner Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med 138 2003 1 9
17. K.L. Margolis, D.E. Bonds, R.J. Rodabough, L. Tinker, L.S. Phillips, and C. Allen Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial Diabetologia 47 2004 1175 1187
18. G.M. Rubanyi, A. Johns, and K. Kauser Effect of estrogen on endothelial function and angiogenesis Vasc. Pharmacol 38 2002 89 98
19. K.L. Chambliss, and P.W. Shaul Estrogen modulation of endothelial nitric oxide synthase Endocr Rev 23 2002 665 686
20. V.M. Miller, T.B. Clarkson, S.M. Harman, E.A. Brinton, M. Cedars, and R. Lobo Women, hormones, and clinical trials: a beginning, not an end J Appl Physiol 99 2005 381 383
21. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587
22. T. Simoncini Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging Climacteric 12 Suppl. 1 2009 6 11
23. K.H. Kim, and J.R. Bender Membrane-initiated actions of estrogen on the endothelium Mol Cell Endocrinol 308 2009 3 8
24. E.R. Levin Integration of the extranuclear and nuclear actions of estrogen Mol Endocrinol 19 2005 1951 1959
25. M.A. Sader, and D.S. Celermajer Endothelial function, vascular reactivity and gender differences in the cardiovascular system Cardiovasc Res 53 2002 597 604
26. D.S. Celermajer, K.E. Sorensen, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J.E. Deanfield Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women J Am Coll Cardiol 24 1994 471 476
27. P. Collins, G.M. Rosano, P.M. Sarrel, L. Ulrich, S. Adamopoulos, and C.M. Beale 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease Circulation 92 1995 24 30
28. K. Miyagawa, J. Rosch, F. Stanczyk, and K. Hermsmeyer Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm Nat Med 3 1997 324 327
29. K. Nakai, C. Itoh, K. Hotta, T. Itoh, M. Yoshizumi, and K. Hiramori Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 beta in human umbilical vein endothelial cells Life Sci 54 1994 PL221 227
30. E. Rodriguez, R. Lopez, A. Paez, F. Masso, and L.F. Montano 17Beta-estradiol inhibits the adhesion of leukocytes in TNF-alpha stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription Life Sci 71 2002 2181 2193
31. L. Nathan, S. Pervin, R. Singh, M. Rosenfeld, and G. Chaudhuri Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis Circ Res 85 1999 377 385
32. P. Gourdy, Z. Mallat, C. Castano, B. Garmy-Susini, J.L. Mac Gregor, and A. Tedgui The atheroprotective effect of 17beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice Atherosclerosis 166 2003 41 48
33. M.R. Adams, J.R. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, and M.S. Wolfe Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone Arteriosclerosis 10 1990 1051 1057
34. T.C. Register, M.R. Adams, D.L. Golden, and T.B. Clarkson Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys Arterioscler Thromb Vasc Biol 18 1998 1164 1171
35. J. Hodgin, and N. Maeda Estrogen and mouse models of atherosclerosis Endocrinology 143 2002 4495 4501
36. P.A. Bourassa, P.M. Milos, B.J. Gaynor, J.L. Breslow, and R.J. Aiello Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice Proc Natl Acad Sci USA 93 1996 10022 10027
37. R. Elhage, J.F. Arnal, M.-T. Pierragi, N. Duverger, C. Fiévet, and J.C. Faye Estradiol-17β prevents fatty streak formation in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 17 1997 2679 2684
38. J. Haarbo, P. Leth-Espensen, S. Stender, and C. Christiansen Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits J Clin Invest 87 1991 1274 1279
39. P. Holm, S. Stender, H.O. Andersen, B.F. Hansen, and B.G. Nordestgaard Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits Arterioscler Thromb Vasc Biol. 17 1997 1504 1511
40. A. Billon-Gales, C. Fontaine, V. Douin-Echinard, L. Delpy, H. Berges, and B. Calippe Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice Circulation 120 2009 2567 2576
41. E.R. Andreeva, I.M. Pugach, and A.N. Orekhov Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro Atherosclerosis 135 1997 19 27
42. K.M. Egan, J.A. Lawson, S. Fries, B. Koller, D.J. Rader, and E.M. Smyth COX-2-derived prostacyclin confers atheroprotection on female mice Science 306 2004 1954 1957
43. R. Elhage, F. Bayard, V. Richard, P. Holvoet, N. Duverger, and C. Fievet Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice Circulation 96 1997 3048 3052
44. E. Van Belle, C. Bauters, T. Asahara, and J.M. Isner Endothelial regrowth after arterial injury: from vascular repair to therapeutics Cardiovasc Res 38 1998 54 68
45. P. Geraldes, M.G. Sirois, P.N. Bernatchez, and J.F. Tanguay Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase Arterioscler Thromb Vasc Biol 22 2002 1585 1590
46. C. Filipe, L. Lam Shang Leen, L. Brouchet, A. Billon, V. Benouaich, and V. Fontaine Estradiol accelerates endothelial healing through the retrograde commitment of uninjured endothelium Am J Physiol 294 2008 H2822 2830
47. C.E. Toutain, C. Filipe, A. Billon, C. Fontaine, L. Brouchet, and J.C. Guery Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization Arterioscler Thromb Vasc Biol 29 2009 1543 1550
48. K. Strehlow, N. Werner, J. Berweiler, A. Link, U. Dirnagl, and J. Priller Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation Circulation 107 2003 3059 3065
49. A. Iwakura, C. Luedemann, S. Shastry, A. Hanley, M. Kearney, and R. Aikawa Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury Circulation 108 2003 3115 3121
50. B. Chandrasekar, and J.F. Tanguay Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model J Am Coll Cardiol 36 2000 1972 1978
51. V. Fontaine, C. Filipe, N. Werner, P. Gourdy, A. Billon, and L. Brouchet Essential role of medullar FGF2 in the effect of estradiol on reendothelialization and EPCs mobilization Am J Pathol 169 2006 1855 1862
52. L.L. Leen, C. Filipe, A. Billon, B. Garmy-Susini, S. Jalvy, and F. Robbesyn Estrogen-stimulated endothelial repair requires osteopontin Arterioscler Thromb Vasc Biol 28 2008 2131 2136
53. G. Foteinos, Y. Hu, Q. Xiao, B. Metzler, and Q. Xu Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice Circulation 117 2008 1856 1863
54. N. Stupka, and P.M. Tiidus Effects of ovariectomy and estrogen on ischemia-reperfusion injury in hindlimbs of female rats J Appl Physiol 91 2001 1828 1835
55. Z.S. Kyriakides, E. Lymberopoulos, A. Papalois, S. Kyrzopoulos, V. Dafnomili, and E. Sbarouni Estrogen decreases neointimal hyperplasia and improves re-endothelialization in pigs Int J Cardiol 113 2006 48 53
56. P.D. Hurn, and L.M. Brass Estrogen and stroke: a balanced analysis Stroke 34 2003 338 341
57. J.A. Delyani, T. Murohara, T.O. Nossuli, and A.M. Lefer Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol J Mol Cell Cardiol 28 1996 1001 1008
58. F.D. Kolodgie, A. Farb, S.H. Litovsky, J. Narula, L.A. Jeffers, and S.J. Lee Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat J Mol Cell Cardiol 29 1997 2403 2414
59. E.A. Booth, N.R. Obeid, and B.R. Lucchesi Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 289 2005 H2039 2047
60. P. Zhai, T.E. Eurell, P.S. Cooke, D.B. Lubahn, and D.R. Gross Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice Am J Physiol Heart Circ Physiol 278 2000 H1640 1647
61. M. Wang, P. Crisostomo, G.M. Wairiuko, and D.R. Meldrum Estrogen receptor-alpha mediates acute myocardial protection in females Am J Physiol Heart Circ Physiol 290 2006 H2204 2209
62. J. Favre, J. Gao, J.P. Henry, I. Remy-Jouet, I. Fourquaux, and A. Billon-Gales Endothelial estrogen receptor {alpha} plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia/reperfusion Arterioscler Thromb Vasc Biol 30 2010 2562 2567
63. C.E. Toutain, L. Brouchet, I. Raymond-Letron, P. Vicendo, H. Berges, and J. Favre Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network Circ Res 104 2009 245 254
64. T. Jover, H. Tanaka, A. Calderone, K. Oguro, M.V. Bennett, and A.M. Etgen Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1 J Neurosci 22 2002 2115 2124
65. J.S. Lewis-Wambi, and V.C. Jordan Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res. 11 2009 206
66. A. Iwakura, S. Shastry, C. Luedemann, H. Hamada, A. Kawamoto, and R. Kishore Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9 Circulation 113 2006 1605 1614
67. S.P. Yun, M.Y. Lee, J.M. Ryu, C.H. Song, and H.J. Han Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: involvement of PKC, PI3K/Akt, and MAPKs Am J Physiol Cell Physiol 296 2009 C317 326
68. M. Wang, J. Tan, A. Coffey, J. Fehrenbacher, B.R. Weil, and D.R. Meldrum Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor production J Thorac Cardiovasc Surg 138 2009 163 171 171 e161
69. J.A. Vita, and J.F. Keaney Jr. Hormone replacement therapy and endothelial function: the exception that proves the rule? Arterioscler Thromb Vasc Biol 21 2001 1867 1869
70. M.E. Rosenfeld, K. Kauser, B. Martin-McNulty, P. Polinsky, S.M. Schwartz, and G.M. Rubanyi Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice Atherosclerosis 164 2002 251 259
71. C.E. Ihionkhan, K.L. Chambliss, L.L. Gibson, L.D. Hahner, M.E. Mendelsohn, and P.W. Shaul Estrogen causes dynamic alterations in endothelial estrogen receptor expression Circ Res 91 2002 814 820
72. C. Pinna, A. Cignarella, P. Sanvito, V. Pelosi, and C. Bolego Prolonged ovarian hormone deprivation impairs the protective vascular actions of estrogen receptor alpha agonists Hypertension 51 2008 1210 1217
73. D.W. Losordo, M. Kearney, E.A. Kim, J. Jekanowski, and J.M. Isner Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women Circulation 89 1994 1501 1510
74. W.S. Post, P.J. Goldschmidt-Clermont, C.C. Wilhide, A.W. Heldman, M.S. Sussman, and P. Ouyang Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system Cardiovasc Res 43 1999 985 991
75. T. Imamura Epigenetic setting for long-term expression of estrogen receptor alpha and androgen receptor in cells Horm Behav 2010
76. B. Darblade, D. Caillaud, M. Poirot, M. Fouque, J.C. Thiers, and J. Rami Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta Cardiovasc Res 50 2001 566 576
77. M. Umetani, H. Domoto, A.K. Gormley, I.S. Yuhanna, C.L. Cummins, and N.B. Javitt 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen Nat Med 13 2007 1185 1192
78. A.V. Finn, M. Nakano, J. Narula, F.D. Kolodgie, and R. Virmani Concept of vulnerable/unstable plaque Arterioscler Thromb Vasc Biol 30 2010 1282 1292
79. A. Tedgui, and Z. Mallat Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 2006 515 581
80. S. Ghisletti, C. Meda, A. Maggi, and E. Vegeto 17{beta}-Estradiol inhibits inflammatory gene expression by controlling NF-{kappa}B intracellular localization Mol Cell Biol 25 2005 2957 2968
81. B. Calippe, V. Douin-Echinard, M. Laffargue, H. Laurell, V. Rana-Poussine, and B. Pipy Chronic estradiol administration in vivo promotes the proinflammatory response of macrophages to TLR4 activation: involvement of the phosphatidylinositol 3-kinase pathway J Immunol 180 2008 7980 7988
82. A. Maret, J.D. Coudert, L. Garidou, G. Foucras, P. Gourdy, and A. Krust Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells Eur J Immunol 33 2003 512 521
83. P. Gourdy, L.M. Araujo, R. Zhu, B. Garmy-Susini, S. Diem, and H. Laurell Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-{gamma} production by invariant natural killer T cells Blood 105 2005 2415 2420
84. J.C. Sluimer, and M.J. Daemen Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis J Pathol 218 2009 7 29
85. D.W. Losordo, and J.M. Isner Estrogen angiogenesis: a review Arterioscler Thromb Vasc Biol 21 2001 6 12
86. G. Pare, A. Krust, R.H. Karas, S. Dupont, M. Aronovitz, and P. Chambon Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury Circ Res 90 2002 1087 1092
87. C.S. Wingrove, E. Garr, I.F. Godsland, and J.C. Stevenson 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells Biochim Biophys Acta 1406 1998 169 174
88. T.B. Clarkson, M.S. Anthony, and J.D. Wagner A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys J Clin Endocrinol Metab 86 2001 5396 5404
89. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
90. G.L. Anderson, R.T. Chlebowski, J.E. Rossouw, R.J. Rodabough, A. McTiernan, and K.L. Margolis Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin Maturitas 55 2006 103 115
91. D.M. Herrington, and K.P. Klein Invited review: pharmacogenetics of estrogen replacement therapy J Appl Physiol 91 2001 2776 2784
92. K.K. Koh, and B.K. Yoon Controversies regarding hormone therapy: insights from inflammation and hemostasis Cardiovasc Res 70 2006 22 30
93. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, and H. Levesque Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Circulation 115 2007 840 845
94. C. Renoux, S. Dell'aniello, E. Garbe, and S. Suissa Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study BMJ 340 2010 2519
95. L. Tora, J. White, C. Brou, D. Tasset, N. Webster, and E. Scheer The human estrogen receptor has two independent nonacidic transcriptional activation functions Cell 59 1989 477 487
96. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474
97. D.P. Edwards Regulation of signal transduction pathways by estrogen and progesterone Annu Rev Physiol 67 2005 335 376
98. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, and O. Smithies Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene Proc Natl Acad Sci USA 90 1993 11162 11166
99. C. Pendaries, B. Darblade, P. Rochaix, A. Krust, P. Chambon, and K.S. Korach The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice Proc Natl Acad Sci USA 99 2002 2205 2210
100. M.D. Iafrati, R.H. Karas, M. Aronovitz, S. Kim, T.R. Sullivan Jr., and D.B. Lubahn Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice Nat Med 3 1997 545 548
101. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes Development 127 2000 4277 4291
102. L. Brouchet, A. Krust, S. Dupont, P. Chambon, F. Bayard, and J.F. Arnal Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta Circulation 103 2001 423 428
103. C. Bolego, A. Cignarella, P. Sanvito, V. Pelosi, F. Pellegatta, and L. Puglisi The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation J Pharmacol Exp Ther 313 2005 1203 1208
104. K.L. Chambliss, Q. Wu, S. Oltmann, E.S. Konaniah, M. Umetani, and K.S. Korach Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice J Clin Invest 120 2010 2319 2330
105. V.C. Jordan The past, present, and future of selective estrogen receptor modulation Ann N Y Acad Sci 949 2001 72 79
106. A. Billon-Gales, C. Fontaine, C. Filipe, V. Douin-Echinard, M.J. Fouque, and G. Flouriot The transactivating function 1 of estrogen receptor {alpha} is dispensable for the vasculoprotective actions of 17{beta}-estradiol Proc Natl Acad Sci USA 106 2009 2053 2058
107. M. Florian, and S. Magder Estrogen decreases TNF-alpha and oxidized LDL induced apoptosis in endothelial cells Steroids 73 2008 47 58